US health officials are reviewing a nearly $600 million contract awarded to Moderna for bird flu vaccines in the final days ...

RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regu ...

Moderna (MRNA) announced that the Medicines and Healthcare products Regulatory Agency in the UK has granted marketing authorization for ...

We believe investors with a long-term horizon should stay invested in MRK stock, while short-term investors should consider selling the same.

The vaccine, manufactured by US pharmaceutical giant Moderna, was found to slash the risk of severe illness from respiratory ...

Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

As it did during the COVID-19 pandemic, mRNA technology offers an efficient way forward in developing products for diseases ...

U.S. health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...